Gland Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,742.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.80 per cent from ₹1,695.36 crore. This corresponds to a year-on-year *(YoY) growth of 22.31 per cent.
Operating Profit
Operating Profit stands at ₹513.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.97 per cent from ₹410.53 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
PBDT
PBDT stands at ₹614.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.80 per cent from ₹469.78 crore. This corresponds to a year-on-year *(YoY) growth of 59.98 per cent.
Profit Before Tax
Profit Before Tax stands at ₹505.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 39.67 per cent from ₹362.13 crore. This corresponds to a year-on-year *(YoY) growth of 75.42 per cent.
Net Profit
Net Profit stands at ₹366.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.23 per cent from ₹261.48 crore. This represents a 96.57 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Gland Pharma Ltd News
Gland Pharma Ltd Earnings
- YOY
- QOQ
Gland Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gland Pharma Ltd Research Reports
Gland Pharma Ltd Financial Reports
Gland Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gland Pharma | -2.50% | 1.71% | 8.72% | 42.46% | 47.99% | 32.43% |
| Abbott India | -1.79% | 1.91% | 0.25% | 1.60% | -6.53% | -23.69% |
| Ipca Labs. | -1.40% | 2.37% | 7.55% | 21.33% | 12.08% | 20.98% |
| Anthem Bioscienc | -2.33% | -2.87% | -3.75% | 3.98% | 19.04% | 2.57% |
| Ajanta Pharma | -1.23% | -2.20% | 8.57% | 18.92% | 18.16% | 24.57% |
| Glaxosmi. Pharma | 0.02% | -0.58% | 9.45% | 1.76% | 1.15% | -27.22% |
| J B Chemicals & | 0.21% | 4.74% | 9.89% | 23.23% | 28.61% | 48.72% |
Company Info
Company Information
Chairman / Executive Director / MD / CEO : SRINIVAS SADU
Independent Non Exe. Director : UDO JAHANNES VETTER
Independent Non Exe. Director : ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Independent Non Exe. Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Wenjie Zhang
Non-Exec & Non-Independent Dir : Wei Huang
CS / Compliance Officer / Vice President : SAMPATH KUMAR PALLERLAMUDI
Additional Director : William Robert Keller